LAS VEGAS, Jan. 8, 2015 /PRNewswire/ — CannaVest Corp. (OTCBB:CANV), a leading manufacturer and distributor of hemp and Cannabidiol (CBD) based products, announces that the results of independent testing have proved the safety and quality of its products. In December, CannaVest Corp. commenced cooperative efforts with Project CBD to ensure the cannabis/hemp industry and the consuming public is provided with accurate and meaningful information concerning CannaVest Corp.’s CBD offerings. Project CBD is a non-profit educational service dedicated to promoting and publicizing research into the medical utility of cannabidiol (CBD).
CannaVest Corp. initiated its cooperative efforts with Project CBD in response to a special report on the hemp oil industry published by Project CBD titled “Hemp Oil Hustlers” on October 14, 2014 and revised on November 5, 2014. Project CBD reported that a consumer product, which is labeled as containing hemp oil and which was produced by the company and then sold in 2013 to a distributor, tested positive for hexane and other solvent residues.
Following the publication of the Project CBD report, CannaVest agreed to work with Project CBD to independently test its products. Based on the results of this testing, Project CBD has concluded that CannaVest Corp.’s products are not contaminated with heavy metals or industrial solvent residues in amounts that pose health and safety issues for consumers, according to officially recognized safety standards. CannaVest and Project CBD have released a joint statement, the full text of which is reprinted below.
“We are proud of our products, our lab processes and personnel and our commitment to quality, which we believe separates us from others in our industry,” stated Michael Mona, Jr., President and Chief Executive Officer of CannaVest. Mr. Mona continued, “[w]e were pleased to work with Project CBD, and through our collaboration with Project CBD, we are happy to report these test results to the public. We are committed to providing the highest quality products on the market today, and the independent testing results bear this out.”
CannaVest Corp. (“CannaVest”) and Project CBD, a non-profit organization, jointly issue this statement:
Project CBD and CannaVest recently had samples of CannaVest’s hemp oil tested by an independent analytical lab as part of a collaborative effort to determine the absence or presence of heavy metals and industrial solvent residues in these products. The results of this independent testing showed only trace levels of solvents and heavy metals that are well below acceptable levels established by the U.S. Pharmacopeial Convention. Based on the results of this limited testing, Project CBD has concluded the CannaVest hemp oil tested is not contaminated with heavy metals or industrial solvent residues in amounts that pose a threat to human health, according to officially recognized safety standards
Project CBD selected six samples from different batches of hemp oil that had been produced by CannaVest since mid-October 2014. Project CBD selected three samples of CannaVest’s CBD Gold™ oil and three samples of CannaVest’s CBD Decarb™ oil for testing.
All samples were submitted to Exova, an independent testing facility based in Santa Fe Springs, California, for analysis. Exova tested the samples for 21 industrial solvents, including hexane, heptane, ethyl acetate, chloroform, toluene, and benzene. Exova also tested these samples to determine the presence or absence of four heavy metals — arsenic, cadmium, lead, and mercury.
On December 18, 2014, and December 23, 2014, Exova issued its findings in two reports to Project CBD and CannaVest. Exova found no significant levels of arsenic, cadmium, lead or mercury in the tested samples. Exova found no detectable levels of 21 industrial solvents in three CBD Gold™ samples. Three samples ofCBD Decarb™ had trace of amounts of toluene that were well below acceptable levels, according to the U.S. Pharmacopeial Convention limit.
These findings do not negate or refute the lab data presented in Project CBD’s original report, “Hemp Oil Hustlers,” as such lab data was based on hemp oil obtained by Project CBD from third parties.
About CannaVest Corp.
CannaVest Corp. (OTCBB:CANV), located in Las Vegas, Nevada, focuses on the procurement and wholesale of the hemp plant extract cannabidiol (CBD), and the development, marketing and sale of end consumer products containing CBD, which is refined into its own PlusCBD Oil™ brand. CannaVest resells raw industrial hemp product to third parties, acquired through supply relationships in Europe. Additional information is available fromOTCMarkets.com or by visiting www.cannavest.com.
CannaVest Corp.’s subsidiaries include: US Hemp Oil, LLC (www.USHempOil.com) that provides seed procurement, cultivation, processing, and production consultation, and equipment to support U.S. farmers, researchers and businesses to cultivate and process industrial hemp in the US; and CannaVest Laboratories, LLC (www.CannaVestLabs.com), that facilitates cutting edge research and develops nutraceutical and food products, containing cannabidiol (CBD) oil, and is the developer and manufacturer of CannaVest’s own award winning CBD Simple™.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of CannaVest Corp. to be materially different from the statements made herein.
CannaVest Corp. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp-based products and is involved with the federally legal distribution of medical marijuana-based products within certain international markets.
2688 S. Rainbow Blvd., Ste. B
Las Vegas, NV 89146